Center for Technological Development in Health/National Institute of Science and Technology for Innovation on Diseases of Neglected Population (INCT-IDPN), FIOCRUZ, Rio de Janeiro 21040-900, Brazil.
Cellular Ultrastructure Laboratory, FIOCRUZ, Oswaldo Cruz Institute, Rio de Janeiro 21040-900, Brazil.
Biomolecules. 2020 Nov 17;10(11):1564. doi: 10.3390/biom10111564.
The increasing detection of infections of , the etiological agent of Chagas disease, in non-endemic regions beyond Latin America has risen to be a major public health issue. With an impact in the millions of people, current treatments rely on antiquated drugs that produce severe side effects and are considered nearly ineffective for the chronic phase. The minimal progress in the development of new drugs highlights the need for advances in basic research on crucial biochemical pathways in to identify new targets. Here, we report on the presenilin-like transmembrane aspartyl enzyme, a protease of the aspartic class in a unique phylogenetic subgroup with separate from protozoans. Computational analyses suggest it contains nine transmembrane domains and an active site with the characteristic PALP motif of the A22 family. Multiple linear B-cell epitopes were identified by SPOT-synthesis analysis with Chagasic patient sera. Two were chosen to generate rabbit antisera, whose signal was primarily localized to the flagellar pocket, intracellular vesicles, and endoplasmic reticulum in parasites by whole-cell immunofluorescence. The results suggest that the parasitic presenilin-like enzyme could have a role in the secretory pathway and serve as a target for the generation of new therapeutics specific to the .
在拉丁美洲以外的非流行地区,不断检测到克氏锥虫感染,这已成为一个主要的公共卫生问题。受影响的人数以百万计,目前的治疗方法依赖于陈旧的药物,这些药物会产生严重的副作用,并且被认为在慢性期几乎无效。在开发新药物方面进展甚微,这突出表明需要在基础研究方面取得进展,以确定 中关键生化途径的新靶点。在这里,我们报告了 早老素样跨膜天冬氨酸酶,这是一种独特的进化枝中属于天冬氨酸的蛋白酶,与原生动物分开。计算分析表明它含有九个跨膜结构域和一个具有 A22 家族特征 PALP 基序的活性位点。通过斑点合成分析用恰加斯病患者的血清鉴定出多个线性 B 细胞表位。选择了两个来产生兔抗血清,通过全细胞免疫荧光,其信号主要定位于寄生虫鞭毛囊中、细胞内囊泡和内质网。结果表明,寄生虫早老素样酶可能在分泌途径中发挥作用,并可作为生成针对 的新型治疗药物的靶标。